bronchiectasis

Pidotimod is a synthetic dipeptide with immunomodulatory properties.

Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.

6-Hydroxyluteolin, a flavonoid compound prepared from the above-ground parts of Salvia amarissima Ortega, inhibits aldose reductase (AR), exhibits antimicrobial activity, and can be used in the study of bronchiectasis and wet gastric diseases.

Indimilast is used to inhibit phosphodiesterase IV that regulates lung inflammation and causes bronchiectasis by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway smooth muscle and inflammatory cells. Potential to treat chronic obst

Pibuterol Acetate is a short-acting beta-2 adrenergic receptor agonist with bronchiectasis and is used as a respiratory activated quantitative inhaler in the treatment of asthma.

GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 is a bioactive dipeptide that can be used for the research of bronchiectasis [1] [2].

A68930 hydrochloride is a dopamine D1 receptor agonist which can be used for the research of bronchiectasis [1].

IA-Alkyne (Iodoacetamide-alkyne) is a TRP channel (TRPC) agonist. IA-Alkyne can be used to develop an isotopically tagged probe for quantitative cysteine-reactivity profiling. It also has the potential for the study of respiratory infection.

GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis.

DPP1-IN-1 (compound 1) serves as a potent DPP1 inhibitor and is utilized in the study of bronchiectasis [1].

Quinoline sulfate has a bronchiectasis effect on patients with asthma.

Bamifylline Hydrochloride, an adenosine A1 receptor antagonist, is uesd to treat bronchiectasis and chronic obstructive pulmonary disease.